Key statistics
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | -- |
Low | -- |
Bid | -- |
Offer | -- |
Previous close | -- |
Average volume | -- |
---|---|
Shares outstanding | 51.14m |
Free float | 50.67m |
P/E (TTM) | 24.24 |
Market cap | 9.93bn USD |
EPS (TTM) | 8.01 USD |
Data delayed at least 15 minutes.
More ▼
Press releases
- Charles River Laboratories to Present at UBS and Jefferies Conferences
- Charles River Laboratories Announces Third-Quarter 2024 Results
- Charles River Launches New Retrogenix® Non-Human Protein Library
- Charles River Laboratories Schedules Third-Quarter 2024 Earnings Release and Conference Call
- Charles River Provides Translational Expertise at Neuroscience 2024
- Charles River and Lundbeck Enter Agreement Utilizing AI-Powered Logica® to Advance the Discovery of Novel Drugs for Neurological Disease
- Charles River Laboratories and CEBINA Announce Strategic Collaboration to Accelerate Cutting Edge Neuroscience Research
- Charles River and Insightec Announce Strategic Collaboration to Advance Therapeutic Development Utilizing Focused Ultrasound in Neuroscience
- Charles River Laboratories to Present at Baird and Morgan Stanley Conferences
More ▼